Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Bedin, Valcinir ^a   Adam, Randall L ^a   de Sá, Bianca C S ^b   Landman, Gilles ^b   Metze, Konradin ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SURVIVAL; CELL NUCLEUS; CHROMATIN; CHROMATIN STRUCTURE; CHROMOSOMAL LOCALIZATION; FEMALE; FRACTAL ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; MITOSIS; PRIMARY TUMOR; PROGNOSIS; RISK FACTOR; TISSUE MICROARRAY; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENETICS; IMAGE PROCESSING; KAPLAN MEIER METHOD; METHODOLOGY; MITOSIS INDEX; MORTALITY; NUCLEAR SIZE; PATHOLOGY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SKIN TUMOR; STAINING; TIME;

COLORING AGENT; DIAGNOSTIC AGENT; EOSIN; HEMATOXYLIN; TUMOR MARKER;

CELL NUCLEUS SIZE; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; COLORING AGENTS; EOSINE YELLOWISH-(YS); FEMALE; FRACTALS; HEMATOXYLIN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KAPLAN-MEIERS ESTIMATE; MALE; MELANOMA; MITOTIC INDEX; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS; STAINING AND LABELING; TIME FACTORS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77953073626     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-260     Document Type: Article

References (50)

1. Carlson JA, Ross JS, Slominski AJ. New techniques in dermatopathology that help to diagnose and prognosticate melanoma. Clinics in Dermatology 2009, 27:75-102. 10.1016/j.clindermatol.2008.09.007, 19095155.
2. Gimotty PA, Botbyl J, Soong SJ, Guerry D. A population-based validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2005, 23:8065-75. 10.1200/JCO.2005.02.4976, 16258105.
3. de Sa BC, Rezze GG, Scramin AP, Landman G, Neves RI. Cutaneous melanoma in childhood and adolescence: retrospective study of 32 patients. Melanoma Res 2004, 14(6):487-92. 10.1097/00008390-200412000-00008, 15577319.
4. de Sá BC, Fugimori ML, Ribeiro Kde C, Duprat Neto JP, Neves RI, Landman G. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas. Melanoma Res 2009, 19(3):135-41. 10.1097/CMR.0b013e32831993f3, 19369901.
5. Neto DS, Pantaleão L, de Sá BC, Landman G. Alpha-v-beta3 integrin expression in melanocytic nevi and cutaneous melanoma. J Cutan Pathol 2007, 34(11):851-6. 10.1111/j.1600-0560.2007.00730.x, 17944725.
6. Bachmann IM, Ladstein RG, Straume O, Naumov GN, Akslen LA. Tumor Necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas. BMC Cancer 2008, 8:362. 10.1186/1471-2407-8-362, 2631589, 19061491.
7. Winklmeier A, Poser I, Hoek KS, Bosserhoff AK. Loss of full length CtBP1 expression enhances the invasive potential of human melanoma. BMC Cancer 2009, 9:52. 10.1186/1471-2407-9-52, 2650708, 19216735.
8. Sousa JF, Esperafico EM. Suppression subtractive hybridization profiles of radial growth phase and metastatic melanoma cell lines reveal novel potential targets. BMC Cancer 2008, 8:19. 10.1186/1471-2407-8-19, 2267200, 18211678.
9. Kaufmann S, Kuphal S, Schubert T, Bosserhoff AK. Functional implication of Netrin expression in malignant melanoma. Cell Oncol 2009, 31(6):415-22.
10. Metze K, Ferreira RC, Adam RL, Leite NJ, Ward LS, de Matos PS. Chromatin texture is size dependent in follicular adenomas but not in hyperplastic nodules of the thyroid. World J Surg 2008, 32(12):2744-6. 10.1007/s00268-008-9736-0, 18787892.
11. Ferreira RC, de Matos PS, Adam RL, Leite NJ, Metze K. Application of the Minkowski fractal dimension for the differential diagnosis in thyroid Follicular neoplasias. Cellular Oncology 2006, 28:5-6.
12. Mello MRB, Metze K, Adam RA, Pereira FG, Magalhães MG, Machado Lorand-Metze I. Phenotypic subtypes of acute lymphoblastic leukemia associated with different nuclear chromatin texture. Analytical and Quantitative Cytology and Histology 2008, 30:175-184.
13. Moro-Rodríguez E, Figols J, Alvira M, Uranga-Ocio JA, García-Poblete E. 13 GFAP and alpha1a-AR staining and nuclear morphometry of oligodendrogliomas by confocal microscopy and image analysis: useful parameters for predicting survival in oligodendrogliomas. Diagn Pathol 2008, 15(3 Suppl 1):S26.
14. Adam RL, Leite NJ, Metze K. Image preprocessing improves Fourier-based texture analysis of nuclear chromatin. Anal Quant Cytol Histol 2008, 30(3):175-84.
15. Metze K, Lorand-Metze IG. Interpretation of the AgNOR pattern in hematologic cytology. Acta Haematol 1993, 89(2):110-2. 10.1159/000204500, 8503243.
16. Li LX, Crotty KA, Palmer AA, Kril JJ, Stankovic R, Scolyer RA, McCarthy SW. Differentiating benign nevi from malignant melanoma using DNA microdensitometry and karyometry and maturation: a zonal comparison, correlation and multivariate analysis. Anal Quant Cytol Histol 2002, 24:234-43.
17. Li LX, Crotty KA, Palmer AA, Kril JJ, Scolyer RA, Thompson JF, McCarthy SW. Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions. Am J Dermatopathol 2003, 25(3):190-7. 10.1097/00000372-200306000-00002, 12775980.
18. Cia EMM, Trevisan M, Metze K. Argyrophilic nucleolar organizer region (AgNOR) technique: a helpful tool for differential diagnosis in urinary cytology.
19. Lorand-Metze I, Carvalho MA, Metze K. Relationship between morphometric analysis of nucleolar organizer regions and cell proliferation in acute leukemias. Cytometry 1998, 32:51-56. 10.1002/(SICI)1097-0320(19980501)32:1<51::AID-CYTO7>3.0.CO;2-I, 9581624.
20. Jondet M, Agoli-Agbo R, Dehennin L. Automatic measurement of epithelium differentiation and classification of cervical intraneoplasia by computerized image analysis. Diagn Pathol 2010, 5:7. 10.1186/1746-1596-5-7, 2819044, 20148100.
21. Adam RL, Silva RC, Pereira FG, Leite NJ, Lorand-Metze I, Metze K. The fractal dimension of nuclear chromatin as a prognostic factor in acute precursor B lymphoblastic leukemia. Cell Oncol 2006, 28(1-2):55-9.
22. Montironi R, Scarpelli M, Lopez-Beltran A, Mazzucchelli R, Alberts D, Ranger-Moore J, Bartels HG, Hamilton PW, Einspahr J, Bartels PH. Chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potential. Cell Oncol 2007, 29(1):47-58.
23. Lebedev DV, Filatov MV, Kuklin AI, Islamov A, Kentzinger E, Pantina R, Toperverg BP, Isaev-Ivanov VV. Fractal nature of chromatin organization in interphase chicken erythrocyte nuclei: DNA structure exhibits biphasic fractal properties. FEBS Lett 2005, 579(6):1465-8. 10.1016/j.febslet.2005.01.052, 15733858.
24. Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A, Amit I, Lajoie BR, Sabo PJ, Dorschner MO, Sandstrom R, Bernstein B, Bender MA, Groudine M, Gnirke A, Stamatoyannopoulos J, Mirny LA, Lander ES, Dekker J. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 2009, 326:289-293. 10.1126/science.1181369, 2858594, 19815776.
25. Bancaud A, Huet S, Daigle N, Mozziconacci J, Beaudouin J, Ellenberg J. Molecular crowding affects diffusion and binding of nuclear proteins in heterochromatin and reveals the fractal organization of chromatin. EMBO J 2009, 28:3785-3798. 10.1038/emboj.2009.340, 19927119.
26. Goutzanis L, Papadogeorgakis N, Pavlopoulos PM, Katti K, Petsinis V, Plochoras I, Pantelidaki C, Kavantzas N, Patsouris E, Alexandridis C. Nuclear fractal dimension as a prognostic factor in oral squamous cell carcinoma. Oral Oncology. 2008, 44(4):345-353.
27. Mashiah A, Wolach O, Sandbank J. Lymphoma and leukemia cells possess fractal dimensions that correlate with their biological features. Acta Haematologica 2008, (119):142-150. 10.1159/000125551, 18417956.
28. Delides A, Panayiotides I, Alegakis A, Kyroudi A, Banis C, Pavlaki A, Helidonis E, Kittas C. Fractal dimension as a prognostic factor for laryngeal carcinoma. Anticancer Res 2005, 25(3B):2141-4.
29. Metze K, Ferro DP, Falconi MA, Adam RL, Ortega M, Lima CP, De Souza AC, Lorand-Metze I. Fractal characteristics of nuclear chromatin in routinely stained cytology are independent prognostic factors in patients with multiple myeloma. Virchows Archiv 2009, 455(S1):7-11.
30. Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. Tissue microarrays for high- throughput molecular profiling of tumor specimens. Nat Med 1998, 4:844-7. 10.1038/nm0798-844, 9662379.
31. Sarkar N, Chaudhuri BB. An efficient differential box-counting approach to computed fractal dimension of images. IEEE Transactions on Systems Man and Cybernetics 1994, 24:115-120.
32. Metze K, Lorand-Metze I, Leite NJ, Adam RL. Goodness-of-fit of the fractal dimension as a prognostic factor. Cell Oncol 2009, 31(6):503-4.
33. Lorand-Metze I, Pinheiro MP, Ribeiro E, de Paula EV, Metze K. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB andWHO classifications. Leukemia Research 2004, 28:587-594. 10.1016/j.leukres.2003.11.001, 15120935.
34. Homsi J, Kashani-Sabet M, Messina JL, Daud A. Cutaneous melanoma:prognostic factors. Cancer Control 2005, 12(4):223-9. 16258493.
35. Li LXL, Crotty KA, Scolyer RA, Thompson JF, Kril JJ, Palmer AA, McCarthy SW. Use of multiple cytometric markers improves discrimination between benign and malignant melanocytic lesions: a study of DNA microdensitometry, karyometry, argyrophilic staining of nucleolar organizer regions and MIB1- Ki67 immunoreactivity. Melanoma Research 2003, 13:581-586. 10.1097/00008390-200312000-00007, 14646621.
36. Kossard S, WilkinsoN B. Nucleolar organizer regions and image-analysis nuclear morphometry of small-cell (nevoid) melanoma. Journal of Cutaneous Pathology 22(2):132-136. 10.1111/j.1600-0560.1995.tb01395.x, 7560345.
37. Rieger E, Hofmann-Wellenhof R, Soyer HP, Kofler R, Cerroni L, Smolle J, Kerl H. Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions. A quantitative immunohistochemical study. J Cutan Pathol 1993, 20:229-36. 10.1111/j.1600-0560.1993.tb00648.x, 8103531.
38. Rother J, Jones D. Molecular markers of tumor progression in melanoma. Curr Genomics 2009, 10(4):231-9. 10.2174/138920209788488526, 2709934, 19949544.
39. Balázs M, Adám Z, Treszl A, Bégány A, Hunyadi J, Adány R. Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization. Cytometry 2001, 46(4):222-32. 10.1002/cyto.1131, 11514955.
40. Misteli T. Beyond the Sequence: Cellular Organization of Genome Function. Cell 2007, 128(4):787-800. 10.1016/j.cell.2007.01.028, 17320514.
41. Gilbert N, Boyle S, Fiegler H, Woodfine K, Carter NP, Bickmore WA. Chromatin architecture of the human genome: gene-rich domains are enriched in open chromatin fibers. Cell 2004, 118:555-566. 10.1016/j.cell.2004.08.011, 15339661.
42. Mascolo M, Vecchione ML, Ilardi G, Scalvenzi M, Molea G, Di Benedetto M, Nugnes L, Siano M, De Rosa G, Staibano S. Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients. BMC Cancer 2010, 10(1):63. 10.1186/1471-2407-10-63, 2843674, 20178651.
43. Rothhammer T, Bosserhoff AK. Epigenetic events in malignant melanoma. Pigment Cell Res 20:92-111. 10.1111/j.1600-0749.2007.00367.x, 17371436.
44. Mossbacher U, Knollmayer S, Binder M, Steiner A, Wolff K, Pehamberger H. Increased nuclear volume in metastasizing "thick" melanomas. J Invest Dermatol 1996, 106(3):437-40. 10.1111/1523-1747.ep12343580, 8648173.
45. Talve LA, Collan YU, Ekfors TO. Primary malignant melanoma of the skin. Relationships of nuclear DNA content, nuclear morphometric variables, Clark level and tumor thickness. Anal Quant Cytol Histol 1997, 19(1):62-74.
46. Mandelbrot BB. Stochastic models for the Earth's relief, the shape and the fractal dimension of the coastlines, and the number-area rule for islands. Proc Natl Acad Sci USA 1975, 72(10):3825-3828. 10.1073/pnas.72.10.3825, 433088, 16578734.
47. Paumgartner D, Losa G, Weibel ER. Resolution effect on the stereological estimation of surface and volume and its interpretation in terms of fractal dimensions. J Microsc 1981, 21(Pt 1):51-63.
48. Grosberg AY, Nechaev S, Shakhnovich E. The role of topological constraints in the kinetics of collapse of macromolecules. J Phys France 49:2095-2100.
49. McNally JG, Mazza D. Fractal geometry in the nucleus. EMBO Journal 2010, 29(1):2-3. 10.1038/emboj.2009.375, 20051993.
50. Gonzato G, Mulargia F, Marzocchi W. Practical application of fractal analysis: Problems and solutions. Geophysical Journal International 1998, 132-275.